Having trouble viewing this email? View in a browser.

You are subscribed to %%list.name%% as %%emailaddr%%. Unsubscribe.

Formulary

Formulary News Capsule

FormularyJournal.com

May 18 , 2012

CLINICAL NEWS

Vitamin D threshold varies with season, study shows

Researchers from the University of Washington have identified a threshold concentration of serum 25-hydroxyvitamin D [25-(OH)D] that is associated with increased risk for major medical events and say that season-specific targets may be more appropriate than static targets when evaluating health risk. » More

CONTINUING EDUCATION

Helping your patients control persistent asthma

Working in partnership with patients and physicians, pharmacists can help ensure optimal control of this common disease.

To read and print the article with TEST QUESTIONS, click here. To proceed to the online exams and earn up to 2 CPE credits, click here to login.

EDITOR’S PICK

MTM by pharmacists helps resolve medication-related problems

In the patient-centered medical home, pharmacists who are practicing at the "top of their license" should be providing medication therapy management to detect, resolve, monitor, and prevent medication-related problems across the continuum of care for patients, according to a presentation at the American Pharmacists Association 2012 annual meeting and exposition in New Orleans. » Click here.

CLINICAL NEWS

Variation in schizophrenia treatment

Patients with schizophrenia who switched from haloperidol decanoate or fluphenazine decanoate to risperidone microspheres discontinued their treatment more frequently, according to a new study published in the March issue of the Journal of Clinical Psychiatry. » More

Study on schizophrenia deaths makes surprising find

A unique study designed to gauge the impact of polypharmacy on schizophrenia mortality produced some surprising results: The use of antidepressants or 2 or more antipsychotics was not associated with increased deaths, but the use of  benzodiazepine was. » More

Warfarin, aspirin similar in treating heart failure

Warfarin fared no better than aspirin at reducing the combined risk of brain hemorrhage, stroke, or death for heart-failure patients in normal rhythm, according to the results of a study published in the New England Journal of Medicine. » More

Survey

With specialty drug products representing the fastest growing component of today’s drug expenditures, which of the following would you rate as the most important service a specialty pharmacy can provide in helping to optimize the quality and cost-efficiency of specialty pharmaceutical care?

a) Waste management
b) Patient risk assessment and education
c) Managing prior authorization of specialty products
d) Outcomes monitoring, reporting, and intervention
e) Helping patients navigate financial assistance programs
f) Adherence programs


Click here and see what your colleagues think, too.

Want to see the results of our last survey regarding healthcare industry trends and which one will have the most significant impact on the ability to manage pharmacy expenditures over the next 3-5 years? Click here.

Twitter  

Follow us on Twitter

Facebook  

Like us on Facebook

Resources

Drug Watch

FDA Actions

Latest News

Medication Safety

Policy Watch

Digital Edition

View current edition

Cover
 
Powered by Modern Medicine Advanstar Medical Communications Group

You are subscribed to %%list.name%% as %%emailaddr%%. Click here to unsubscribe or edit your member profile.

To ensure delivery to your inbox, please add us to your address book. If you need help doing this, Click here.

Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, simply call (toll free) 866-529-2922 at any time, or fax us at 218-740-6417. Outside the U.S., please phone 218-740-6395. Contact us by mail at Advanstar Communications Inc., 131 West First St., Duluth, MN 55802-2065, USA.